Alps Medical Breakthroughs ETF (SBIO)

$45.00 0.96 (2.10%)

20:00 EDT SBIO Stock Quote Delayed 30 Minutes

7 Health-Focused ETFs To Buy Now For the Post-Covid Future

By Tezcan Gecgil, InvestorPlace Contributor Apr 29, 2021

The healthcare sector outperformed in the past year due to the pandemic. Here are seven ETFs for your portfolio to look beyond Covid-19.

7 Biotech ETFs to Buy Now For Covid-19 And Beyond

7 of the Best Healthcare ETFs to Purchase for 2020

7 of the Best Healthcare ETFs to Purchase for 2020

More Articles

Volume:

Previous Close -

Market Cap 2.03M

PE Ratio -

EPS -

Volume (Avg. Vol.) 11,393

Day's Range 44.96 - 45.79

52-Week Range 41.54 - 64.04

Dividend & Yield 0.58 (1.29%)

SBIO Stock Predictions, Articles, and Alps Medical Breakthroughs ETF News

From InvestorPlace
From the Web

7 Biotech ETFs That Should Remain Healthy

By Todd Shriber, InvestorPlace Contributor Aug 5, 2019

The healthcare sector has been the worst performing on the S&P 500 in 2019, but these biotech ETFs are still worth a look.

7 of the Best Biotech ETFs

By Todd Shriber, InvestorPlace Contributor Feb 27, 2019

Amid ongoing industry consolidation, attractive valuations and a strong broad market, catalysts are in place for more upside for biotech ETFs.

5 of the Best Thematic ETFs to Consider

By Todd Shriber, InvestorPlace Contributor Feb 14, 2019

If you're looking to invest in a particular corner of the market, odds are good there's a thematic ETF for you. Here are 5 to take a look at.

7 Biotech ETFs to Consider for 2019

By Todd Shriber, InvestorPlace Contributor Nov 20, 2018

Biotech ETFs lagged in 2018, but that doesn't mean there aren't healthcare funds to consider for 2019.

10 Best ETFs for 2018: Still a Close Race at the Head of the Pack

By Jessica Loder, InvestorPlace Assistant Editor Oct 10, 2018

As the Best ETFs contest enters its final quarter, there are a few contenders that could reasonably take the trophy for 2018.

Best ETFs for 2018: Don’t Sweat This Quarter for the SBIO ETF

By Todd Shriber, InvestorPlace Contributor Sep 28, 2018

On a year-to-date basis, SBIO still looks good, up 14.30%, or 310 basis points better than the Nasdaq Biotechnology Index. Year-to-date, SBIO is also outpacing the equal-weight S&P Biotechnology Select Industry Index.

10 ETFs to Buy for a Rally

By Todd Shriber, InvestorPlace Contributor Sep 6, 2018

The bull market has been going on for a long time, but if you want to focus on securities with some growth left, these are great ETFs to buy.

5 ETFs That Will Beat the S&P 500 in Q3

By Todd Shriber, InvestorPlace Contributor Jul 12, 2018

The third quarter is a notoriously tricky time for stocks, but that doesn't mean you can't continue to profit. Here are some ETFs to buy to beat the market in Q3.

10 Best ETFs for 2018: Biotechs Top the Charts at the Midpoint

By Jessica Loder, InvestorPlace Assistant Editor Jul 11, 2018

As our Best ETFs for 2018 contest crosses into the second half of the year, a few contestants are really making standout gains, but others are making strong moves.

5 Small-Cap ETFs and Stocks Crushing the Russell 2000

By Zacks Investment Research May 21, 2018

We have presented five ETFs & stocks that have easily crushed the Russell 2000 index this year and are likely to continue their strong performance. Compare....

5 Biotech ETFs for Outsized Gains

By Todd Shriber, InvestorPlace Contributor Apr 25, 2018

Data support the notion that biotechnology stocks offer outperformance potential over diversified healthcare benchmarks. And these 5 biotech ETFs are a great to play the space.

10 Best ETFs for 2018: A Tumultuous First Quarter

By Jessica Loder, InvestorPlace Assistant Editor Apr 3, 2018

While some of the contenders have been gravitating toward the top or bottom, it's still very much anyone's game in the Best ETFs for 2018 contest.

Best ETFs For 2018: A Solid Start for the ALPS Medical Breakthroughs ETF

By Todd Shriber, InvestorPlace Contributor Mar 27, 2018

My pick for the Best ETFs contest, SBIO, is outpacing the Nasdaq Biotechnology Index by 600 basis points with the first quarter drawing to a close.

7 Best Healthcare ETFs for the Rest of 2018

By Todd Shriber, InvestorPlace Contributor Mar 8, 2018

Some of the best healthcare ETFs to buy are more "traditional", while others focus on very specific areas of the industry. These seven healthcare ETFs should deliver for investors over the remainder of 2018.

10 Best ETFs for 2018: Funds at the Starting Line

By Jessica Loder, InvestorPlace Assistant Editor Jan 18, 2018

Which funds are going to kick the competition to the curb this year? We have 10 experts who think they know the best ETFs for 2018.

Best ETFs for 2018: Break Through With the ALPS Medical Breakthroughs ETF

By Todd Shriber, InvestorPlace Contributor Jan 10, 2018

Trying to pick just the right biotech stock to invest in? The ALPS Medical Breakthroughs ETF (SBIO) eases that burden.

3 Biotech ETFs for Decades of Big Returns

By Aaron Levitt, InvestorPlace Contributor Nov 15, 2016

It doesn't matter who is in charge; biotech stocks will always be major growth engines. Here are three of the best biotech ETFs to buy.

4 Frightful ETFs of This Year (VXX, TAPR, KWT, BBC)

By Zacks Investment Research Oct 28, 2016

Let's take a look Inside four heavily losing ETFs in the year-to-date frame.

Bet on a Bounce with These Biotech ETFs

By Todd Shriber, InvestorPlace Contributor Oct 13, 2015

Biotech stocks may have taken a beating lately, but that may just make these biotech ETFs more of a bargain.

5 Best ETFs Right Now

By Jeff Reeves Jul 10, 2015

The best ETFs so far in 2015 include some lesser-known funds dealing in niches like small-cap health care and Japanese financials.

Top-Performing Biotech ETFs of Last Week

From Talk Markets Jun 15, 2021

Investors may want to tap the bullishness in the biotech sector with the best biotech ETFs of last week.

5 Small-Cap Sector ETFs Leading the Russell 2000 Rally

From Talk Markets Jun 9, 2021

Here are five ETFs from different sectors that have easily crushed the Russell 2000 Index over the past month and are likely to continue their strong performance for the rest of the year.

Medical Miracles Inside Biotech ETFs

From Talk Markets May 24, 2021

The events of the past year focused a lot of attention on game changing developments made possible by the global biotech industry. Of the major names Moderna is the one where the original research and patents for COVID-19 vaccines were developed.

5 Small-Cap Sector ETFs Beating the Russell 2000

From Talk Markets Dec 16, 2020

Here are five ETFs that have easily crushed the Russell 2000 Index over the past three months and are likely to continue their strong performance heading into the New Year.